| Previous Close | N/A |
| YTD Return | N/A |
| Expense Ratio (net) | N/A |
| Category | N/A |
| Last Cap Gain | N/A |
| Morningstar Rating | N/A |
| Morningstar Risk Rating | N/A |
| Sustainability Rating | N/A |
| Net Assets | N/A |
| Beta (5Y Monthly) | N/A |
| Yield | N/A |
| 5y Average Return | N/A |
| Holdings Turnover | N/A |
| Last Dividend | N/A |
| Average for Category | N/A |
| Inception Date | N/A |
- GlobeNewswire
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2022
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 29 April 2022 at 13:00 CET. Please find the notice to the Annual General Meeting attached and relevant documents referred to in the notice are made available on www.hofsethbiocare.com. For further information, please contact: Jon Olav Ødegård, CFO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer
- GlobeNewswire
Hofseth Biocare ASA: HBC ANNUAL REPORT 2021
Today, 25 March 2022, the Board of Directors of Hofseth BioCare ASA approved the Annual Report for 2021. Please find the Annual Report 2021 and ESG Report attached. For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 93632966E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new drug leads. Research is ongoing to identify the individual elements within its ingredien
